Search results
Swiss approve law boosting renewable energy generation
AFP via Yahoo News· 3 days agoSwitzerland approved a law on Sunday aimed at accelerating the development of renewable energies, as...
Swiss authorities want to use a new climate bill approved last year to boost wind and solar power's...
The Port Lavaca Wave· 6 days agoSwiss authorities want to use a new climate bill approved last year to boost wind and solar power's...
Swiss renewable energy battle moves to the ballots
AFP via Yahoo News· 6 days agoSwitzerland's largest wind farm, sitting astride the ridge of the Jura mountains by the French border, consists of only 16 turbines -- tiny compared to...
Swiss Voters Back More Green Energy, Reject Health-Insurance Cap
Bloomberg· 3 days agoSwiss voters backed a government plan to boost domestic renewable energy, a decision that will make...
Swiss vote on renewable energy plan for 2050 carbon neutrality | FOX 28 Spokane
FOX 28 Spokane· 4 days agoSwiss voters were expected to approve in a referendum Sunday a law aimed at accelerating the...
Opiate-based painkiller 'ten times stronger than Tramadol' not banned, worries cycling's authorities
Cycling Weekly· 7 hours agoTapentadol was raised at a meeting of the Professional Cycling Council last month, according...at...
Freestyle BMX Riders To Watch Ahead Of Paris 2024 Olympics: Nikita Ducarroz
Forbes· 1 day agoNow, ahead of Paris 2024, Ducarroz is ranked No. 5 in the world and is the top Swiss athlete, all...
THE SWISS HELVETIA FUND, INC. DECLARES QUARTERLY DISTRIBUTION OF $0.129 PER SHARE
The Pilot News· 5 days agoThe Swiss Helvetia Fund, Inc. (NYSE: SWZ), a non-diversified registered closed-end investment company (the "Fund"), announced today a quarterly distribution of $0.129 per ...
Doctors would not administer assisted-dying drugs in proposed law
BBC News· 6 hours agoTerminally ill residents would have to self administer an approved substance to end their lives...
NLS Pharmaceutics Announces Publication of New Patent Application for Next-Gen Dual Non-Sulfonamide...
Digital Journal· 1 day ago...others, could cause actual results to differ materially from those described in the forward-looking statements: changes in technology and market requirements; NLS may encounter delays or obstacles in launching and/or successfully completing its clinical trials; NLS' products may not be approved...